蔡建強，1962年生，籍貫吉林，中國醫學科學院腫瘤醫院腹部腫瘤外科專業，主任醫師，博士生導師。1980年考入白求恩醫科大學臨床醫學專業，1985年獲得學士學位。1985年進入中國醫學科學院腫瘤醫院腹部外科工作，1998年晉升為副主任醫師，2003年晉升為主任醫師。1994年08月-1995年05月在德國海涅大學血管外科中心訪問學習，2000年08月-2001年08月在日本熊本大學醫學部第一外科做訪問學者。2013年獲中央黨校國際政治專業碩士學位。

致力于腹部惡性腫瘤（原發性肝癌、結直腸癌肝轉移、軟組織肉瘤、神經內分泌腫瘤及胃腸間質瘤等）以外科治療為主的綜合治療及轉化醫學研究。建立并倡導“穩、準、輕、快、狠”的手術安全體系；踐行并推廣MDT理念。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

<sup id="51g4i"></sup>

1. Qichen Chen#, Rui Zhang#, Baocai Xing#, Cong Li#, Dianrong Xiu#, Jinghua Chen, Yiqiao Deng, Xiao Chen, Rui Guo, Fenglin Chen, Jianhong Peng, Tao Sun, Hangyan Wang, Muxing Li, Qiwen Zheng, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Zhiyu Li, Zhen Huang, Yefan Zhang, Yizhou Zhang, Jianqiang Cai*, Hong Zhao*. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study. Int J Surg. 2022;106952. (IF:13.400)

2. Qichen Chen#, Zilin Li#, Jiangyuan Yu, Qing Xie, Haizhen Lu, Yiqiao Deng, Jinghua Chen, Wenjia Zhu, Li Huo, Yizhou Zhang, Wei Song, Jianqiang Lan, Jianqiang Cai*, Zhen Huang*, Zixi Wang* & Hong Zhao*. Novel gold nanoparticles targeting somatostatin receptor subtype two with near-infrared light for neuroendocrine tumour therapy. Nano Research.2022;15:9149–9159. (IF:10.269)

3. Wen Zhang#, Caifeng Gong#, Xuenan Peng, Xinyu Bi, Yongkun Sun, Jianguo Zhou, Fan Wu, Huiying Zeng, Yan Wang, Hui Zhou, Hong Zhao*, Jianqiang Cai*, Aiping Zhou*. Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients. Clin Cancer Res.2022;28(16):3499-3508. (IF:13.801)

4. Juxian Sun#, Rongping Guo#, Xinyu Bi#, Mengchao Wu, Zhaoyou Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong , Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Gong Li, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Huichuan Sun, Kaishan Tao, Gaojun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xuting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhaochong Zeng, Kangshun Zhu, Minshan Chen*, Jianqiang Cai*, Shuqun Cheng*. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition). Liver Cancer.2022;11(4):315-328. (IF:12,430)

5. Yongkun Sun#, Wen Zhang#, Xinyu Bi#, Zhengqiang Yang#, Yu Tang#, Liming Jiang#, Feng Bi, Minshan Chen, Shuqun Cheng, Yihebali Chi, Yue Han, Jing Huang, Zhen Huang , Yuan Ji, Liqun Jia, Zhichao Jiang, Jing Jin, Zhengyu Jin, Xiao Li, Zhiyu Li, Jun Liang, Lianxin Liu, Yunpeng Liu, Yinying Lu, Shichun Lu, Qinghua Meng, Zuoxing Niu, Hongming Pan, Shukui Qin, Wang Qu, Guoliang Shao, Feng Shen, Tianqiang Song, Yan Song, Kaishan Tao, Aiping Tian, Jianhua Wang, Wenling Wang, Zhe Wang, Liqun Wu, Feng Xia, Baocai Xing, Jianming Xu, Huadan Xue, Dong Yan, Lin Yang, Jianming Ying, Jingping Yun, Zhaochong Zeng, Xuewen Zhang, Yanqiao Zhang, Yefan Zhang, Jianjun Zhao, Jianguo Zhou, Xu Zhu, Yinghua Zou, Jiahong Dong, Jia Fan, Wan Yee Lau, Yan Sun, Jinming Yu, Hong Zhao*, Aiping Zhou*, Jianqiang Cai*. Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements. Liver Cancer.2022;11(3):192-208. (IF:12,430)

6. Jianyang Wang#, Hong Zhao#, Jing Yu#, Xin Xu, Hao Jing, Ning Li, Yuan Tang, Shulian Wang, Yexiong Li, Jianqiang Cai*, Jing Jin*. MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling. Cancer Sci.2021;112(2):575-588.(IF:6.716)

7. Shuqun Cheng#*, Minshan Chen#*, Jianqiang Cai#*, Juxian Sun, Rongping Guo, Xinyu Bi, Wan Yee Lau, Mengchao Wu. Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer.2020;9(1):28-40. (IF:11.740)

8. Yihebali Chi#, Zhiwei Fang, Xiaonan Hong, Yang Yao, Ping Sun, Guowen Wang, Feng Du, Yongkun Sun, Qiong Wu, Guofan Qu, Shusen Wang, Jianmin Song, Jianchun Yu, Yongkui Lu, Xia Zhu, Xiaohui Niu, Zhiyong He, Jinwan Wang, Hao Yu, Jianqiang Cai*. Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. Clin Cancer Res.2018;24(21):5233-5238. (IF:8.911 F1000)

9. Fanxin Zeng#, Xiao Chen#, Weiyi Cui#, Wei Wen, Fujian Lu, Xueting Sun, Dongwei Ma, Ye Yuan, Zezhong Li, Ning Hou, Hong Zhao, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Yan Zhang, Rui-Ping Xiao, Jianqiang Cai*, Xiuqin Zhang*. RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca²⁺ Uptake and Promotes Colorectal Oncogenesis. Cancer Res.2018;78(11):2876-2885.(IF:8.378)

10. Meng Li#, Hong Zhao#, Xiaosong Zhang, Laura D Wood, Robert A Anders, Michael A Choti, Timothy M Pawlik, Hubert D Daniel, Rajesh Kannangai, G Johan A Offerhaus, Victor E Velculescu, Linfang Wang, Shibin Zhou, Bert Vogelstein, Ralph H Hruban, Nick Papadopoulos, Jianqiang Cai*, Michael S Torbenson* & Kenneth W Kinzler*. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet.2011;43(9):828-9. (IF:35.532 C100)